These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12431683)
1. Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis. Koselj-Kajtna M; Koselj M; Rott T; Kandus A; Bren A Transplant Proc; 2002 Nov; 34(7):3001-2. PubMed ID: 12431683 [No Abstract] [Full Text] [Related]
2. Organ transplantation in the vasculitides. Schmitt WH; van der Woude FJ Curr Opin Rheumatol; 2003 Jan; 15(1):22-8. PubMed ID: 12496506 [TBL] [Abstract][Full Text] [Related]
3. Adverse effects of therapy for ANCA-associated vasculitis. Turnbull J; Harper L Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946 [TBL] [Abstract][Full Text] [Related]
4. Vasculitis and infection: effects of immunosuppressive therapy. Lode HM; Schmidt-Ioanas M Clin Nephrol; 2005 Dec; 64(6):475-9. PubMed ID: 16370163 [TBL] [Abstract][Full Text] [Related]
5. Outcome of renal transplantation in patients with both ANCA and anti-GBM antibodies. Raman G; Srivastava A; Geetha D Transplantation; 2012 Sep; 94(5):e30-1. PubMed ID: 22955170 [No Abstract] [Full Text] [Related]
7. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis. Jones R; Shah S; MacMahon EE; Goldsmith DJ Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244 [No Abstract] [Full Text] [Related]
8. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Stegeman CA Nephrol Dial Transplant; 2002 Dec; 17(12):2077-80. PubMed ID: 12454214 [No Abstract] [Full Text] [Related]
9. The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis. Pusey CD J Am Soc Nephrol; 2006 May; 17(5):1221-3. PubMed ID: 16624927 [No Abstract] [Full Text] [Related]
10. Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis. Masterson R; Sheerin N; Abbs I; Goldsmith D Nephrol Dial Transplant; 2001 Aug; 16(8):1705-7. PubMed ID: 11477180 [No Abstract] [Full Text] [Related]
11. Late renal allograft rupture in a patient with small vessel vasculitis following discontinuation of immunosuppression. Zakir AH; Woodside KJ; Feliberti EC; Rajaraman S; Gugliuzza KK; Daller JA Transpl Int; 2003 Oct; 16(10):761-4. PubMed ID: 12827233 [TBL] [Abstract][Full Text] [Related]
13. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)]. Kötter I Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987 [No Abstract] [Full Text] [Related]
14. Anti-glomerular basement membrane and anti-neutrophil cytoplasm antibody-positive vasculitis presenting with peripheral neuropathy and acute renal failure. Tang S; Chan KW; Chan TM; Lui SL; Cheng IK Nephron; 1998; 79(2):225-6. PubMed ID: 9647509 [No Abstract] [Full Text] [Related]
15. Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantation. Grotz W; Wanner C; Röther E; Schollmeyer P Nephron; 1995; 69(3):234-6. PubMed ID: 7753254 [TBL] [Abstract][Full Text] [Related]
16. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo. Tabata H; Honda K; Moriyama T; Itabashi M; Taneda S; Takei T; Tanabe K; Teraoka S; Yamaguchi Y; Oda H; Nitta K Clin Transplant; 2009 Aug; 23 Suppl 20():49-53. PubMed ID: 19594597 [TBL] [Abstract][Full Text] [Related]
17. Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis. Walsh M; Tonelli M; Jayne D; Manns B J Nephrol; 2007; 20(2):119-29. PubMed ID: 17514615 [No Abstract] [Full Text] [Related]